Innovation

Emily Leproust, PhD, co-founder and CEO of Twist Bioscience, spoke with MIT Technology Review about why DNA strands may be the next frontier in the emerging data storage market.

A team of researchers from Danville, Pa.-based Geisinger and genetic sequencing provider Regeneron Genetics Center recently discovered a gene variant associated with a significant reduction in a patient's risk of developing chronic liver disease.

The IQVIA Institute for Human Data Science, a research and analysis organization affiliated with health IT company IQVIA, released 10 predictions on the future of healthcare March 13.

Verb Surgical is working to develop a better, cheaper surgical robot that features a slew of software tools capable of recording insights from procedures — and with partners like Google and Johnson & Johnson, it may eventually change the way…

Medial EarlySign, a developer of artificial intelligence-powered software tools, raised $30 million in a recent funding round, according to Reuters.

In an effort to accelerate early intervention, an international team of researchers developed an artificial intelligence tool to screen patients for various eye diseases.

New York City-based NewYork-Presbyterian was named a top 10 most innovative company in artificial intelligence by Fast Company in  its annual ranking.

Los Angeles-based Cedars-Sinai Medical Center partnered with Boston-based organs-on-chip provider Emulate to establish a precision medicine program, the organizations confirmed Feb. 20.

Genomics companies in the U.S. received $2.52 billion in venture capital funding in 2017, up 142 percent from $1.04 billion in 2016, according to a joint report by PwC and CB Insights.

The number of consumers who underwent direct-to-consumer genetic testing surpassed 4 million in 2017, almost double the 2.6 million who reported doing so in 2016, according to an analysis by MIT Technology Review senior editor for biomedicine Antonio Regalado.